Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T McCarty

Showing results (231-240 of 288) with videos related to

Pageof 29
Sort By:
Journal of Thrombosis and Haemostasis : JTH|March 30, 2022
Revised model of the tissue factor pathway of thrombin generation: Role of the feedback activation of FXIHari Hara Sudhan Lakshmanan, Aldrich Estonilo, Stéphanie E Reitsma, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 1, 2019
Contact Activation Inhibitor and Factor XI Antibody, AB023, Produces Safe, Dose-Dependent Anticoagulation in a Phase 1 First-In-Human TrialChristina U Lorentz, Norah G Verbout, Michael Wallisch, et al.
Journal of Thrombosis and Haemostasis : JTH|May 31, 2022
Pharmacological reduction of coagulation factor XI reduces macrophage accumulation and accelerates deep vein thrombosis resolution in a mouse model of venous thrombosisKelley R Jordan, Cory R Wyatt, Meghan E Fallon, et al.
The Journal of Biological Chemistry|October 1, 2005
Rac1 is essential for platelet lamellipodia formation and aggregate stability under flowOwen J T McCarty, Mark K Larson, Jocelyn M Auger, et al.
Blood|August 19, 2024
Coagulation factor XI regulates endothelial cell permeability and barrier function in vitro and in vivoCristina Puy, Samantha A Moellmer, Jiaqing Pang, et al.
JACC. Cardiovascular Imaging|September 18, 2010
Molecular imaging of activated von Willebrand factor to detect high-risk atherosclerotic phenotypeOwen J T McCarty, Robert B Conley, Weihui Shentu, et al.
Cellular and Molecular Bioengineering|August 25, 2020
Design of a Microfluidic Bleeding Chip to Evaluate Antithrombotic Agents for Use in COVID-19 PatientsHari Hara Sudhan Lakshmanan, Adity A Pore, Tia C L Kohs, et al.
European Journal of Haematology|July 31, 2023
Estrogen-based hormonal therapy and the risk of thrombosis in COVID-19 patientsCorinne LaVasseur, Rick Mathews, Jenny S H Wang, et al.
Blood|January 25, 2020
The protein C activator AB002 rapidly interrupts thrombus development in baboonsErik I Tucker, Norah G Verbout, Brandon D Markway, et al.
Plos One|May 11, 2010
Spatial distribution of factor Xa, thrombin, and fibrin(ogen) on thrombi at venous shearMichelle A Berny, Imke C A Munnix, Jocelyn M Auger, et al.
Pageof 29

Showing results (231-240 of 288) with videos related to

Sort By:
Pageof 29
Journal of Thrombosis and Haemostasis : JTH|March 30, 2022
Revised model of the tissue factor pathway of thrombin generation: Role of the feedback activation of FXIHari Hara Sudhan Lakshmanan, Aldrich Estonilo, Stéphanie E Reitsma, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 1, 2019
Contact Activation Inhibitor and Factor XI Antibody, AB023, Produces Safe, Dose-Dependent Anticoagulation in a Phase 1 First-In-Human TrialChristina U Lorentz, Norah G Verbout, Michael Wallisch, et al.
Journal of Thrombosis and Haemostasis : JTH|May 31, 2022
Pharmacological reduction of coagulation factor XI reduces macrophage accumulation and accelerates deep vein thrombosis resolution in a mouse model of venous thrombosisKelley R Jordan, Cory R Wyatt, Meghan E Fallon, et al.
The Journal of Biological Chemistry|October 1, 2005
Rac1 is essential for platelet lamellipodia formation and aggregate stability under flowOwen J T McCarty, Mark K Larson, Jocelyn M Auger, et al.
Blood|August 19, 2024
Coagulation factor XI regulates endothelial cell permeability and barrier function in vitro and in vivoCristina Puy, Samantha A Moellmer, Jiaqing Pang, et al.
JACC. Cardiovascular Imaging|September 18, 2010
Molecular imaging of activated von Willebrand factor to detect high-risk atherosclerotic phenotypeOwen J T McCarty, Robert B Conley, Weihui Shentu, et al.
Cellular and Molecular Bioengineering|August 25, 2020
Design of a Microfluidic Bleeding Chip to Evaluate Antithrombotic Agents for Use in COVID-19 PatientsHari Hara Sudhan Lakshmanan, Adity A Pore, Tia C L Kohs, et al.
European Journal of Haematology|July 31, 2023
Estrogen-based hormonal therapy and the risk of thrombosis in COVID-19 patientsCorinne LaVasseur, Rick Mathews, Jenny S H Wang, et al.
Blood|January 25, 2020
The protein C activator AB002 rapidly interrupts thrombus development in baboonsErik I Tucker, Norah G Verbout, Brandon D Markway, et al.
Plos One|May 11, 2010
Spatial distribution of factor Xa, thrombin, and fibrin(ogen) on thrombi at venous shearMichelle A Berny, Imke C A Munnix, Jocelyn M Auger, et al.
Pageof 29